US5075478AExpiredUtility

Process for preparing prostaglandins

Assignee: SEARLE & COPriority: Jan 17, 1991Filed: Jan 17, 1991Granted: Dec 24, 1991
Est. expiryJan 17, 2011(expired)· nominal 20-yr term from priority
C07C 405/00
61
PatentIndex Score
7
Cited by
2
References
14
Claims

Abstract

A process for preparing prostaglandin derivatives by reacting a trans bis-tin ethylene with an organo metal compound then with a compound selected from an epoxide, aldehyde, or ketone, then, without isolation and in the same reaction vessel, reacting with an organo lithium compound, a cuprate complex and a cyclopentenone to produce a prostaglandin intermediate having an unprotected hydroxyl group on the omega side chain.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A process for preparing prostaglandin derivatives comprising reacting in a single reaction vessel a bis tin ethylene of the formula wherein R is independently lower alkyl, alkenyl, phenyl, naphthyl, phenanthryl or thienyl; with an organo metal compound of the formula     R.sup.1 M.sub.n     wherein n is either 1 or 2, M is selected from lithium, copper and magnesium, and R 1  is selected from lower alkyl or a group having the formula ##STR48## wherein Y is --CN, --SCN, --OSO 2  CF 3  or --S-phenyl, and R 2  is lower alkyl;   adding a compound selected from an epoxide, aldehyde and a ketone;   adding an organo lithium compound and a cuprate complex and reacting with a cyclopentenone compound of the formula ##STR49##  wherein n is 0 or 1; R 3  is an alkyl, alkenyl, alkynyl group of 1 to 6 carbon atoms   R 4  is an oxygen protector group; and   R 5  is hydrogen or a lower alkyl group to produce a prostaglandin intermediate.     
     
     
       2. A process as recited in claim 1 wherein the organo metal compound has the formula ##STR50## 
     
     
       3. A process as recited in claim 2 wherein Y is --CN. 
     
     
       4. A process as recited in claim 3 wherein R 2  is methyl. 
     
     
       5. A process as recited in claim 1 wherein the organo lithium compound has the formula   R.sup.1 Li     and R 1  is a lower alkyl group.   
     
     
       6. A process as recited in claim 1 wherein R is a lower alkyl group. 
     
     
       7. A process as recited in claim 6 wherein R is a butyl group. 
     
     
       8. A process as recited in claim 1 wherein an epoxide is added. 
     
     
       9. A process as recited in claim 1 wherein an aldehyde is added. 
     
     
       10. A process as recited in claim 1 wherein a ketone is added. 
     
     
       11. A process as recited in claim 1 wherein M is lithium. 
     
     
       12. A process as recited in claim 1 wherein the organo lithium compound is n-butyl lithium. 
     
     
       13. A process as recited in claim 1 wherein the cuprate complex has the formula   RCu(Y)Li     wherein n is 1 or 2 and R 8  is a lower alkyl.   
     
     
       14. A process as recited in claim 1 further comprising the step of acidifyinq the prostaglandin intermediate to deprotect the hydroxyl group on the cyclopentane ring.

Join the waitlist — get patent alerts

Track US5075478A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.